Design, Synthesis and Preliminary Antimicrobial Evaluation of N-Alkyl Chain Tethered C-5 Functionalized Bis-Isatins.
暂无分享,去创建一个
Nisha | Vipan Kumar | Amandeep Singh | Luisa W. Cheng | A. Debnath | K. Land | C. Tam | Luisa W Cheng | N. Nisha | T. Bains | Hye Jee Hahn | Nicole Liu | J. Kim | Jong H Kim | Christina C Tam | Luisa W. Cheng
[1] Vipan Kumar,et al. 4-Aminoquinoline-chalcone/-N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation. , 2017, European journal of medicinal chemistry.
[2] Vipan Kumar,et al. Piperazine‐linked 4‐aminoquinoline‐chalcone/ferrocenyl‐chalcone conjugates: Synthesis and antiplasmodial evaluation , 2017, Chemical biology & drug design.
[3] Vipan Kumar,et al. 4-Aminoquinoline-ferrocenyl-chalcone conjugates: Synthesis and anti-plasmodial evaluation. , 2017, European journal of medicinal chemistry.
[4] L. Eckmann,et al. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis , 2016, European journal of medicinal chemistry.
[5] H. Abdel‐Aziz,et al. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents. , 2016, European journal of medicinal chemistry.
[6] Vipan Kumar,et al. Synthesis and antiprotozoal activity of mono- and bis-uracil isatin conjugates against the human pathogen Trichomonas vaginalis. , 2015, Bioorganic & medicinal chemistry.
[7] Sun Park,et al. Novel cathepsin B and cathepsin B-like cysteine protease of Naegleria fowleri excretory–secretory proteins and their biochemical properties , 2014, Parasitology Research.
[8] Nisha,et al. Cu(I)Cl-promoted synthesis of novel N-alkylated isatin analogs with an extension toward isatin-4-aminoquinoline conjugates: in vitro analysis against Trichomonas vaginalis , 2014, Medicinal Chemistry Research.
[9] J. Gut,et al. Hsp90 Inhibitors as New Leads To Target Parasitic Diarrheal Diseases , 2014, Antimicrobial Agents and Chemotherapy.
[10] Vipan Kumar,et al. 7‐Chloroquinoline–isatin Conjugates: Antimalarial, Antitubercular, and Cytotoxic Evaluation , 2014, Chemical biology & drug design.
[11] Nisha,et al. N-Propargylated isatin-Mannich mono- and bis-adducts: Synthesis and preliminary analysis of in vitro activity against Tritrichomonas foetus , 2014, European Journal of Medicinal Chemistry.
[12] Nisha,et al. Design and synthesis of β-amino alcohol based β-lactam–isatin chimeras and preliminary analysis of in vitro activity against the protozoal pathogen Trichomonas vaginalis , 2013 .
[13] Vipan Kumar,et al. Synthesis of 1H-1,2,3-triazole linked β-lactam-isatin bi-functional hybrids and preliminary analysis of in vitro activity against the protozoal parasite Trichomonas vaginalis. , 2013, European journal of medicinal chemistry.
[14] S. Hales,et al. Potential effects of global environmental changes on cryptosporidiosis and giardiasis transmission. , 2013, Trends in parasitology.
[15] J. McKerrow,et al. Corifungin, a New Drug Lead against Naegleria, Identified from a High-Throughput Screen , 2012, Antimicrobial Agents and Chemotherapy.
[16] M. Arendrup,et al. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] M. Arkin,et al. A high throughput drug screen for Entamoeba histolytica identifies a new lead and target , 2012, Nature Medicine.
[18] C.-C. Shu,et al. Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] S. West,et al. Mechanisms of Pathogenesis, Infective Dose and Virulence in Human Parasites , 2012, PLoS pathogens.
[20] Vipan Kumar,et al. Synthesis and in vitro cytotoxic evaluation of N-alkylbromo and N-alkylphthalimido-isatins. , 2011, Bioorganic & medicinal chemistry letters.
[21] P. Upcroft,et al. Hydrogenosomes of Laboratory‐Induced Metronidazole‐Resistant Trichomonas vaginalis Lines are Downsized While Those from Clinically Metronidazole‐Resistant Isolates Are Not , 2010, The Journal of eukaryotic microbiology.
[22] R. Fichorova. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. , 2009, Journal of reproductive immunology.
[23] F. Hilberg,et al. Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120). , 2009, Journal of medicinal chemistry.
[24] Maureen Miller,et al. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. , 2008, The Journal of infectious diseases.
[25] R. Roskoski,et al. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. , 2007, Biochemical and biophysical research communications.
[26] J. Baeten,et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.
[27] P. Marynen,et al. Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate , 2006, Clinical Cancer Research.
[28] W. Secor,et al. Trichomonas vaginalis-Induced Epithelial Monolayer Disruption and Human Immunodeficiency Virus Type 1 (HIV-1) Replication: Implications for the Sexual Transmission of HIV-1 , 2005, Infection and Immunity.
[29] Hans Briem,et al. From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐Inhibitors , 2005, Chembiochem : a European journal of chemical biology.
[30] B. Yoon,et al. Metronidazole-induced encephalopathy , 2004, Journal of the Neurological Sciences.
[31] I. M. El-Ashmawy,et al. Reproductive and cytogenetic toxicity of metronidazole in male mice. , 2004, Basic & clinical pharmacology & toxicology.
[32] P. Greengard,et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. , 2004, Journal of medicinal chemistry.
[33] P. Moodley,et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] P. Upcroft,et al. Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa , 2001, Clinical Microbiology Reviews.
[35] P. Upcroft,et al. Efficacy of New 5-Nitroimidazoles against Metronidazole-Susceptible and -Resistant Giardia,Trichomonas, and Entamoeba spp , 1999, Antimicrobial Agents and Chemotherapy.
[36] T. Quinn,et al. Diagnosis of Trichomonas vaginalisInfection by PCR Using Vaginal Swab Samples , 1998, Journal of Clinical Microbiology.
[37] Z. F. Zhang,et al. Trichomonas vaginalis and cervical cancer. A prospective study in China. , 1995, Annals of epidemiology.
[38] J. Krieger. Trichomoniasis in Men: Old Issues and New Data , 1995, Sexually transmitted diseases.
[39] J. Walsh,et al. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. , 1986, Reviews of infectious diseases.
[40] M. Kidwai. Isatins: A Diversity Orientated Biological Profile , 2014 .
[41] R. Figlin,et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] D. Soper. Trichomoniasis: under control or undercontrolled? , 2004, American journal of obstetrics and gynecology.
[43] P. Piot,et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. , 1993 .
[44] D. Keister. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[45] L S Diamond,et al. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.